Ten clinically healthy cats were allotted into 2 groups. Group A was given the low (60 ml), and group B was given the high (120 ml) recommended dose of a commercial hypertonic sodium phosphate enema. Enema retention was enforced. All cats developed clinical and/or laboratory abnormalities, with group B cats being more severely affected. Clinical signs that occurred rapidly included depression, ataxia, vomition, bloody diarrhea, mucous membrane pallor, and stupor; tetany was not seen. One cat in group B died. Laboratory abnormalities included hypernatremia, hyperphosphatemia, hypocalcemia, hyperglycemia, calculated hyperosmolality, and metabolic acidosis with high anion gap probably due to hyperlacticacidemia. There were no significant gross or microscopic lesions associated with enema administration. Therefore, the use of hypertonic sodium phosphate enema at recommended doses is potentially dangerous to cats.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Letter re: A Pre-post Intervention Study Examining the Impact of a Novel Process on Administration Time for Emergent 23.4% Hypertonic Sodium Chloride Boluses.
J Pharm Pract
December 2024
Department of Pharmacy, Upstate University Hospital, Syracuse, NY, USA.
cRGD-Conjugated Bilirubin Nanoparticles Alleviate Dry Eye Disease Via Activating the PINK1-Mediated Mitophagy.
Invest Ophthalmol Vis Sci
November 2024
Department of Ophthalmology, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, People's Republic of China.
Purpose: The purpose of this study was to evaluate the cytoprotective effect and the mechanism of cRGD-conjugated bilirubin nanoparticles (cNPs@BR) in dry eye disease (DED).
Methods: The binding capacity and cellular uptake of cNPs@BR in human corneal epithelial cells (HCECs) were assessed by immunofluorescence. The anti-inflammation and anti-oxidative stress effects of cNPs@BR were determined by flow cytometry, immunofluorescence, Western blot, chromatin immunoprecipitation (ChIP), and ELISA assay in LPS-stimulated RAW264.
Severe Hyponatremia Caused by the Syndrome of Inappropriate Antidiuresis Due to Urinary Retention.
Cureus
November 2024
Department of Internal Medicine, Municipal Omori Hospital, Yokote, JPN.
Article Synopsis
- A 90-year-old woman experienced severe low sodium levels (hyponatremia) due to syndrome of inappropriate antidiuresis (SIAD) caused by urinary retention.
- Her symptoms included worsening fatigue over 10 days, and treatment with hypertonic saline and bladder catheterization improved her condition.
- The case emphasizes that urinary retention can trigger SIAD in patients with unexplained low sodium levels, and highlights the need for careful sodium monitoring to avoid serious complications.
Exposing mice to extremely hypertonic treatments: a recurring problem in lactate research.
J Physiol
November 2024
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
The Safety and Efficacy of Hypertonic Saline in Achieving Primary Fascial Closure Following Damage Control Laparotomy: A Systematic Review and Meta-Analysis.
Cureus
September 2024
General Surgery, University of Malta, Malta, MLT.
Article Synopsis
- Effective fluid management is crucial for patients undergoing damage control laparotomy (DCL) due to trauma or sepsis, with hypertonic saline (HTS) proposed as a better alternative to isotonic fluids.
- A systematic review found that HTS significantly improved early primary fascial closure (EPFC) rates and reduced the time to fascial closure compared to isotonic fluids, while also requiring less total fluid.
- Although HTS led to higher peak sodium levels, no significant differences were noted in renal function or mortality rates between the two fluid types.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!